Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Glac Biotech Co. Ltd. has 3 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 3 examiners and 2 art units, showing distinct examiner assignments with some shared technical-unit context.
ARIANI, KADE is the busiest examiner, with 1 pending matter. Counsel should compare recurring claim and disclosure issues across the matters, while adapting each response to the specific examiner and art-unit setting.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (33%) |
| Double-patenting + other | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ARIANI, KADE | 1 | 75.0% | +32.0% |
| GOUGH, TIFFANY MAUREEN | 1 | 31.7% | +46.5% |
| EDWARDS, JESSICA FAYE | 1 | 38.3% | +47.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18806076 | METHOD FOR INCREASING CALCIUM ABSORPTION USING CULTURE OF LACTOBACILLUS PLANTARUM PL-02 | GOUGH, TIFFANY MAUREEN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19051381 | BACTERIAL STRAIN COMPOSITION FOR INCREASING ENTEROCHROMAFFIN CELL NUMBER AND REDUCING CORTISOL LEVEL | ARIANI, KADE | — |
| 18806076 | METHOD FOR INCREASING CALCIUM ABSORPTION USING CULTURE OF LACTOBACILLUS PLANTARUM PL-02 | GOUGH, TIFFANY MAUREEN | — |
| 18444872 | USE OF LACTOBACILLUS PLANTARUM STRAIN, ITS METABOLITE, OR COMPOSITION CONTAINING THE SAME STRAIN FOR REPAIRING OR PREVENTING RETINAL DAMAGE | EDWARDS, JESSICA FAYE | — |
| Art Unit | Apps |
|---|---|
| 1651 | 2 |
| 1657 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19051381 | BACTERIAL STRAIN COMPOSITION FOR INCREASING ENTEROCHROMAFFIN CELL NUMBER AND REDUCING CORTISOL LEVEL | ARIANI, KADE | 1651 | §112 | Non-Final OA | — | Pending | Feb 12, 2025 |
| 18806076 | METHOD FOR INCREASING CALCIUM ABSORPTION USING CULTURE OF LACTOBACILLUS PLANTARUM PL-02 | GOUGH, TIFFANY MAUREEN | 1651 | §102§103§112 | Non-Final OA | — | Pending | Aug 15, 2024 |
| 18444872 | USE OF LACTOBACILLUS PLANTARUM STRAIN, ITS METABOLITE, OR COMPOSITION CONTAINING THE SAME STRAIN FOR REPAIRING OR PREVENTING RETINAL DAMAGE | EDWARDS, JESSICA FAYE | 1657 | §103§112DP | Non-Final OA | — | Pending | Feb 19, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGlac Biotech Co. Ltd. has 3 pending office actions as of October 2026, spread across 2 art units and 3 examiners.
Kade Ariani has the most, with 1 of Glac Biotech Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
